Altered sphingomyelinase and ceramide expression in the setting of ischemic and nephrotoxic acute renal failure

Kidney International

Volumn 53, Issue 3, 1998, Pages 573-582

  Zager, Richard A ^a   Conrad, Scott ^b   Lochhead, Karen ^b   Sweeney, Elizabeth A ^b   Igarashi, Yasuyuki ^b   Burkhart, K M ^b  

^a Fred Hutchinson Cancer Center and University of Washington   (United States)

^b NONE

Author keywords

Acute renal failure; Ceramide; Enzyme activity; Injury; Sphingomyelinase

Indexed keywords

CERAMIDE; SPHINGOMYELIN PHOSPHODIESTERASE;

ACUTE KIDNEY FAILURE; ANIMAL EXPERIMENT; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL DIFFERENTIATION; CELL PROLIFERATION; INFLAMMATION; KIDNEY ISCHEMIA; KIDNEY PROXIMAL TUBULE; MALE; MOUSE; NEPHROTOXICITY; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN EXPRESSION;

EID: 0031890997     PISSN: 00852538     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1523-1755.1998.00772.x     Document Type: Article

References (54)

1. ZHANG Y, KOLESNICK R: Signaling through the sphingomyelin pathway. Endocrinology 136:4157-4160, 1995
2. HANNUN Y: The sphingomyelin cycle and second messenger function of ceramide. J Biol Chem 269:3125-3128, 1994
3. TESTI R: Sphingomyelin breakdown and cell fate. Trend Biochem Sci 21:468-471, 1996
4. HANNUN YA: Functions of ceramide in coordinating cellular responses to stress. Science 274:1855-1859, 1996
5. OBEID LM, HANNUN YA: Ceramide: A stress signal and mediator of growth suppression and apoptosis. J Cell Biochem 58:191-198, 1995
6. MATHIAS S, KOLESNICK R: Ceramide: A novel second messenger. Adv Lipid Res 25:65-90, 1993
7. KIM MY, LINARDIC C, OBEID L, HANNUN YA: Identification of sphingomyelin turnover as an effector mechanism for the action of tumor necrosis factor alpha and gamma-interferon. Specific role in cell differentiation. J Biol Chem 266:484-489, 1991
8. 2 production and sphingomyelin metabolism. Evidence for the regulation of cyclooxygenase gene expression by sphingosine and ceramide. J Biol Chem 267:20044-20050, 1992
9. DOBROWSKY RT, WERNER MH, CASTELLINO AM, CHAO MV, HANUN YA: Activation of the sphingomyelin cycle through the low-affinity neurotrophin receptor. Science 265:1596-1599, 1994
10. 3-induced HL-60 cell differentiation. J Biol Chem 265:15823-15831, 1990
11. STRUM JC, SMALL G, PAUIG SB, DANIEL LW: 1-Beta-D arabinofuranosylcytosine stimulates ceramide and diglyceride formation in HL-60 cells. J Biol Chem 269:15493-15497, 1994
12. ZHANG J, ALTER N, REED JC, BORNER C, OBEID LM, HANNUN YA: Bcl-2 interrupts the ceramide-mediated pathway of cell death. Proc Natl Acad Sci USA 93:5325-5328, 1996
13. JAYADEV S, LIU B, BIELAWSKA AE, LEE JY, NAZAIRE R, PUSHKAREVA M, OBEID LM, HANNUN YA: Role of ceramide in cell cycle arrest. J Biol Chem 270:2047-2052, 1994
14. SPIEGEL S, MERRILL AH JR: Sphingolipid metabolism and cell growth regulation. FASEB 10:1388-1397, 1996
15. SABA JD, OBEID LM, HANNUN YA: Ceramide: An intracellular mediator of apoptosis and growth suppression. Philosphical Trans Royal Soc London-Series B: Biol Sci 351:233-240, 1996
16. SPIEGEL S, MILSTEIN S: Sphingolipid metabolites: Members of a new class of lipid second messengers. J Membr Biol 146:225-237, 1995
17. BUEHER BM, BELL RM: Sphingosine kinase: Properties and cellular functions. Adv Lipid Res 26:59-67, 1993
18. LIU B, HANNUN YA: Inhibition of the neutral magnesium-dependent sphingomyelinase by glutathione. J Biol Chem 272:16281-16287, 1997
19. SPENCE MW: Sphingomyelinases. Adv Lipid Res 26:3-23, 1993
20. QUINTERN LE, WEITZ G, NEHRKORN H, TAGER JM, SCHRAM AW, SANDHOFF K: Acid sphingomyelinase from human urine: Purification and characterization. Biochim Biophys Acta 922:323-326, 1987
21. CHATTERJEE S: Neutral sphingomyelinase. Adv Lipid Res 26:25-48, 1993
22. 3-induced HL-60 cell differentiation. J Biol Chem 269:4070-4077, 1994
23. 2+ stimulated sphingomyelinase in fetal bovine brain. J Biol Chem 264:5358-5363, 1989
24. ZAGER RA, IWATA M, CONRAD DS, BURKHART KM, IGARASHI Y: Altered ceramide and sphingosine expression during the induction phase of ischemic acute renal failure. Kidney Int 52:60-70, 1997
25. ZAGER RA: Mitochondrial free radical production induces lipid peroxidation during myohemoglobinuria. Kidney Int 49:741-751, 1996
26. 2-induced cytoprotection of proximal tubules: Potential determinants and specificity for ATP depletion-mediated injury. J Am Soc Nephrol 7:64-72, 1996
27. COUSER WG, SALANT DJ, STILMANT MM, ARBEIT LA, DARBY C, SLIOGERIS VG: The effects of aminonucleoside of puromycin and nephrotoxic serum on subepithelial immune deposit formation in passive Heymann nephritis. J Lab Clin Med 94:917-932, 1979
28. QUINTERN LE, SANDHOFF K: Human acid sphingomyelinase from human urine. Methods Enzymol 197:536-540, 1991
29. CHATTERJEE S, GHOSH N: Purification of neutral sphingomyelinase from human urine. Methods Enzymol 197:540-547, 1991
30. YOUNES A, KAHN DW, BESTERMAN WR, BITTMAN R, BYUN H-S, KOLESNICK RN: Ceramide is a competitive inhibitor of diacylglycerokinase in vitro and in intact human leukemia (HL-60) cells. J Biol Chem 267:842-847, 1992
31. VAN VELDHOVEN PP, MANNAERTS GP: Inorganic and organic phosphate measurements in the nanomolar range. Anal Biochem 161:45-48, 1987
32. FINK J, COOPER M, BURKHART K, ZAGER RA: Marked enzymuria following bone marrow transplantation: A correlate of veno-occlusive disease-induced "hepatorenal syndrome." J Am Soc Nephrol 6:1655-1660, 1995
33. MATTHYS E, PATEL Y, KREISBERG J, STEWART JH, VENKATACHALAM MA: Lipid alterations induced by renal ischemia: Pathogenic factor in membrane damage. Kidney Int 26:153-161, 1984
34. GOERING PL, FISHER BR, CHAUDHARY PP, DICK CA: Relationship beteen stress protein induction in rat kidney by mercuric chloride nephrotoxicity. Toxicol Appl Pharmacol 113:184-191, 1992
35. WILKS MF, KWIZERA EN, BACH PH: Assessment of heavy metal toxicity in vitro using isolated rat glomeruli and proximal tubular fragments. Renal Physiol Biochem 13:275-284, 1990
36. IWATA M, ZAGER RA: Myoglohin induces transient growth arrest in cultured human proximal tubular cells. Kidney Int 50:796-804, 1996
37. ZAGER RA: Rhabdomyolysis and myohemoglobinuric acute renal failure. (Perspectives in Clinical Nephrology) Kidney Int 49:314-326, 1996
38. WEINBERG JM: The cell biology of ischemic renal injury. (Editorial Review) Kidney Int 39:476-500, 1991
39. BOSE R, VERHEIJ M, HAIMOVITZ-FRIEDMAN A, SCOTTO K, FUKS Z, KOLESNICK R: Ceramide synthase mediates daunorubicin-induced apoptosis: An alternative mechanism for generating death signals. Cell 82:405-414, 1995
40. ZAGER RA, FUERSTENBERG SM, BAEHR PH, MYERSON D, TOROK-STORB B: An evaluation of antioxidant effects on recovery from postischemic acute renal failure. J Am Soc Nephrol 4:1588-1597, 1994
41. BERRI R, SYMON Z, BREZIS M, BEN-SASSON SA, BAEHR PH, ROSEN S, ZAGER RA: Rapid DNA fragmentation from hypoxia along the thick ascending limb of rat kidneys. Kidney Int 47:1806-1810, 1995
42. SHAH SV: Apoptosis. J Lab Clin Med 124:169-177, 1994
43. LIEBERTHAL W, LEVINE JS: Mechanisms of apoptosis and its potential role in renal tubular cell injury. Am J Physiol 271:F477-F488, 1996
44. 2 and cyclo-oxygenase 2. Biochem Biophys Res Commun 220:681-686, 1996
45. BRINDLEY DN, ABOUSALHAM A, KIKUCHI Y, WANG CN, WAGGONER DW: "Cross talk" between the bioactive glycerolipids and sphingolipids in signal transduction. Biochem Cell Biol 74:469-476, 1996
46. 2. Biochem Biophys Res Commun 220:834-838, 1996
47. HONDA N, HISHIDA A, IKUMA K, YONEMURA K: Acquired resistance to acute renal failure. Kidney Int 31:1233-1238, 1987
48. 2 deprivation injury, possibly by inducing uremia. Kidney Int 45:1760-1768, 1994
49. ZAGER RA, BALTES LA: Progressive renal insufficiency induces increasing protection against ischemic acute renal failure. J Lab Clin Med 103:511-523, 1984
50. VOGT BA, SHANLEY TP, CROATT A, ALAM J, JOHNSON KJ, NATH KA: Glomerular inflammation induces resistance to tubular injury in the rat. A novel form of acquired, heme oxygenase-dependent resistance to renal injury. J Clin Invest 98:2139-2145, 1996
51. IWATA M, HERRINGSTON J, ZAGLR RA: Sphingosine: A mediator of acute renal tubular injury and subsequent cytoresistance. Proc Nat Acad Sci USA 92:8970-8974, 1995
52. WONG K, LI XB, HUNCHUK N: N-acetylsphingosine (C2-ceramide) inhibited neutrophil superoxide formation and calcium influx. J Biol Chem 270:3056-3062, 1995
53. CAI Z, BETTAIEB A, MAHDANI NE, LEGRIS LG, STANCOU R, MASLIAH J, CHOUAIB S: Alteration of the sphingomyelin/ceramide pathway is associated with resistance of human breast carcinoma MCF7 cells to tumor necrosis factor-alpha-mediated cytotoxicity. J Biol Chem 272: 6918-6926, 1997
54. CHMURA SJ, NODZENSKI E, BECKETT MA, KUFE DW, QUINTANS J, WEICHSELBAUM RR: Loss of ceramide production confers resistance to radiation-induced apoptosis. Cancer Res 57:1270-1275, 1997